The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pelabresib (CPI-0610) monotherapy in high-risk essential thrombocythemia refractory or intolerant to hydroxyurea: Preliminary results from MANIFEST study.
 
Francesco Passamonti
Consulting or Advisory Role - Novartis
Speakers' Bureau - Celgene; Novartis
Travel, Accommodations, Expenses - Abbvie
 
Andrea Patriarca
Consulting or Advisory Role - Sanofi; SOBI
Speakers' Bureau - Incyte; Novartis Italy
 
Steven Knapper
Honoraria - Jazz Pharmaceuticals
Consulting or Advisory Role - Abbvie; Astellas Pharma; Jazz Pharmaceuticals; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Jazz Pharmaceuticals
 
Candido Rivera
No Relationships to Disclose
 
Joseph Scandura
Stock and Other Ownership Interests - Cellectis; Protagonist Therapeutics; Scholar Rock
Consulting or Advisory Role - Abbvie; CTI BioPharma Corp; MorphoSys; Pharmaessentia; SDP Oncology
 
Timothy Devos
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Incyte; Novartis
 
Nikki Granacher
Consulting or Advisory Role - Alexion Pharmaceuticals; Alexion Pharmaceuticals; Bristol-Myers Squibb/Celgene; Novartis
Travel, Accommodations, Expenses - Abbvie; Incyte
 
Adam J. Mead
Stock and Other Ownership Interests - Alethiomics
Honoraria - Abbvie; Celgene/Bristol-Myers Squibb; Constellation Pharmaceuticals; CTI; Karyopharm Therapeutics; Novartis
Research Funding - Alethiomics; Celgene/Bristol-Myers Squibb; Galecto; Novartis
Patents, Royalties, Other Intellectual Property - AJM is co-founder and equity holder in Alethiomics Ltd, a spin out company from the University of Oxford. AJM has licensed a patent to Alethiomics.
 
Stephen Oh
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; Cogent Biosciences; Constellation Pharmaceuticals; CTI BioPharma Corp; Geron; Incyte; Protagonist Therapeutics; Sierra Oncology
Research Funding - Actuate Therapeutics (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb/Celgene (Inst); Cogent Biosciences (Inst); Constellation Pharmaceuticals (Inst); CTI (Inst); Incyte (Inst); Ionis Pharmaceuticals (Inst); Kartos Therapeutics (Inst); Pharmaessentia (Inst); Sierra Oncology (Inst); Takeda (Inst)
 
Jeanne M. Palmer
Research Funding - Constellation Pharmaceuticals (Inst); CTI BioPharma Corp (Inst); Incyte (Inst); PharmaEssentia (Inst); Protagonist Therapeutics (Inst); Sierra Oncology (Inst)
 
Raajit Rampal
Honoraria - Protagonist Therapeutics
Consulting or Advisory Role - Abbvie; Blueprint Medicines; Bristol-Myers Squibb/Celgene; Constellation Pharmaceuticals; CTI BioPharma Corp; Disc Medicine; Galecto; Incyte; Karyopharm Therapeutics; Novartis; Pharmaessentia; Promedior; SERVIER; Sierra Oncology; Stemline Therapeutics; Sunimoto Dainippon; Zentalis
Research Funding - Constellation Pharmaceuticals; Ryvu Therapeutics; Stemline Therapeutics; Zentalis
Travel, Accommodations, Expenses - Incyte; Sierra Oncology
 
Lino Teichmann
Honoraria - AOP Orphan Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); SOBI (Inst)
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Jazz Pharmaceuticals; Pfizer; SOBI
Travel, Accommodations, Expenses - AOP Orphan Pharmaceuticals; BeiGene
 
Jie Cui
Employment - Lilly O.
Stock and Other Ownership Interests - Lilly O.
Travel, Accommodations, Expenses - Lilly O.
 
Sandra Klein
Employment - Constellation Pharmaceuticals
Stock and Other Ownership Interests - MorphoSys
 
Gozde Colak
Employment - Constellation Pharmaceuticals
Stock and Other Ownership Interests - MorphoSys
 
Claire Harrison
Honoraria - Abbvie; CTI BioPharma Corp; Geron; Janssen; Novartis
Consulting or Advisory Role - AOP Orphan Pharmaceuticals; Celgene; Constellation Pharmaceuticals; CTI; Galecto; Geron; Gilead Sciences; Janssen; Keros Therapeutics; Novartis; Promedior; Roche; Shire; Sierra Oncology
Speakers' Bureau - Abbvie; Bristol-Myers Squibb; CTI BioPharma Corp; Geron; Novartis; Sierra Oncology
Research Funding - Bristol-Myers Squibb (Inst); Constellation Pharmaceuticals (Inst); Novartis (Inst)